CSF neurofilament light chain but not FLT3 ligand discriminates Parkinsonian disorders
The differentiation between multiple system atrophy (MSA) and Parkinson’s disease (PD) is difficult, particularly in early disease stages. Therefore, we aimed to evaluate the diagnostic value of neurofilament light chain (NFL), fms-like tyrosine kinase ligand (FLT3L) and total tau protein (t-tau) in...
Main Authors: | Megan Kristy Herbert, Marjolein B Aerts, Marijke eBeenes, Niklas eNorgren, Rianne A J Esselink, Bastiaan R Bloem, H Bea eKuiperij, Marcel M Verbeek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00091/full |
Similar Items
-
A Computational Model of Neurofilament Kinetics Relating Axonal Caliber Growth and the Neurofilament Slowing Phenomenon
by: Friedman, Anika J.
Published: (2019) -
The Effect of Charcot-Marie-Tooth Disease Mutations in Neurofilament Light on Neurofilaments
by: Stone, Elizabeth J.
Published: (2020) -
Neurofilament light as a marker for neurodegenerative diseases
by: Norgren, Niklas
Published: (2004) -
The biology and targeting of FLT3 in pediatric leukemia
by: Colleen eAnnesley, et al.
Published: (2014-09-01) -
The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy
by: Francisco J. Cueto, et al.
Published: (2021-03-01)